Skin Allergy — Causes, Types, Symptoms & Treatment Guide — Symptoms, Causes & Treatment | MyMedicPlus

Skin allergy is an umbrella term for hypersensitivity reactions affecting the skin, including atopic dermatitis (eczema), allergic contact dermatitis, urticaria (hives), and angioedema. These conditions arise when the immune system overreacts to normally harmless substances (allergens), releasing histamine and other mediators that cause inflammation, itching, and rash. Skin allergies collectively affect 10-20% of the global population and represent one of the most common reasons for dermatology consultation. Atopic dermatitis alone affects 15-30% of children and 2-10% of adults worldwide. The burden includes significant quality-of-life impairment, sleep disturbance, and psychological distress. Most skin allergies are chronic conditions requiring long-term management strategies rather than one-time treatment. Early intervention, allergen identification, and tailored treatment strategies are critical for preventing chronic progression and minimising the psychological burden of living with a chronic inflammatory skin condition. Combined dermatology and allergy specialist input significantly improves long-term outcomes and quality of life for affected patients.

Skin allergies arise from IgE-mediated (immediate hypersensitivity) or T-cell-mediated (delayed hypersensitivity) immune reactions. Common allergens causing contact dermatitis include nickel (jewelry, belt buckles), fragrances and preservatives (cosmetics, shampoos), latex, formaldehyde (household products), hair dyes (p-phenylenediamine), and topical medications (neomycin). Urticaria triggers include foods (nuts, shellfish, eggs, dairy), medications (penicillin, NSAIDs, ACE inhibitors), insect stings, latex, cold or heat, pressure, and infections. Atopic dermatitis is driven by a defective skin barrier (filaggrin gene mutations), immune dysregulation toward Th2 responses, and environmental triggers. Risk factors include a personal or family history of atopy (asthma, hay fever, eczema), exposure to environmental pollutants, and low microbial diversity in early childhood.

Symptoms vary by type of skin allergy. Atopic dermatitis presents with intense pruritus (itching), dry skin, red or brownish-gray patches on flexural surfaces (elbows, knees, ankles, wrists, neck), small raised fluid-filled bumps that may weep when scratched, and thickened, cracked, or scaly skin. Allergic contact dermatitis produces localized itching, redness, swelling, and blistering at the site of allergen contact after 24-72 hours. Urticaria causes transient raised, itchy wheals (hives) appearing anywhere on the body, lasting minutes to hours but changing location. Angioedema involves deeper swelling of the face, lips, tongue, throat, hands, or genitals and can be life-threatening if the airway is compromised. Chronic spontaneous urticaria persists beyond 6 weeks without identifiable trigger.

Diagnosis is primarily clinical, based on history, morphology and distribution of lesions, and trigger identification. Patch testing (epicutaneous testing using Finn chambers with standardized allergen series) identifies contact allergens in suspected allergic contact dermatitis — read at 48 and 96 hours. Skin prick testing or serum-specific IgE (RAST/ImmunoCAP) tests identify immediate hypersensitivity to foods, latex, and environmental allergens causing urticaria. Total serum IgE and eosinophil count may support atopic diagnosis. In chronic urticaria, investigate for underlying causes: thyroid autoantibodies, ANA, FBC, CRP, and urinalysis. Provocation tests (cold, pressure, exercise) are performed for physical urticarias. Skin biopsy is occasionally needed to exclude other dermatological diagnoses mimicking allergic conditions.

The cornerstone of management is allergen avoidance once the trigger is identified. Topical therapies: emollients (moisturizers) applied frequently are the foundation of atopic dermatitis treatment, restoring the skin barrier; topical corticosteroids (hydrocortisone 1% for mild, betamethasone for severe) reduce inflammation; topical calcineurin inhibitors (tacrolimus, pimecrolimus) are steroid-sparing options. Oral antihistamines: non-sedating (cetirizine, loratadine, fexofenadine) for urticaria — doses can be up-titrated to 4x standard dose before adding second-line agents. Systemic treatments: oral prednisolone for severe flares; cyclosporine, methotrexate, or azathioprine for severe atopic dermatitis. Biologics: dupilumab (anti-IL-4/IL-13) is highly effective for moderate-to-severe atopic dermatitis; omalizumab (anti-IgE) for chronic urticaria refractory to antihistamines. Allergen immunotherapy desensitizes selected patients. Wet wrap therapy — moisturiser-soaked bandages applied over topical corticosteroids — is effective for severe acute atopic dermatitis flares, particularly in children, providing rapid itch relief and reducing the need for systemic therapy. Patient education about trigger avoidance and the correct application technique for topical treatments is equally essential for achieving long-term disease control and reducing flare frequency.

Untreated or poorly managed skin allergies cause significant systemic and psychological harm. Chronic uncontrolled atopic dermatitis causes skin barrier failure with increased susceptibility to secondary bacterial infection (Staphylococcus aureus skin colonisation occurs in over 90% of AD patients and triggers flares), eczema herpeticum (widespread herpes simplex infection causing life-threatening dissemination requiring IV aciclovir), and fungal superinfection. Chronic itch-scratch cycles cause lichenification (skin thickening), permanent scarring, and hyperpigmentation. Children with severe uncontrolled eczema have significantly disrupted sleep — resulting in cognitive impairment, poor school performance, and behavioural difficulties. Approximately 40-60% of children with severe eczema develop asthma and allergic rhinitis — the atopic march — reinforcing the importance of early eczema treatment. Chronic urticaria causes severe psychological distress with high rates of anxiety (40-50%) and depression; quality of life impairment is comparable to coronary artery disease. Unrecognised angioedema affecting the throat can cause fatal airway obstruction without prompt epinephrine treatment. Occupational allergic contact dermatitis may require career change if exposure cannot be eliminated.

Prevention centers on allergen identification and avoidance. Wear nickel-free jewelry, fragrance-free cosmetics, and use sensitive-skin labeled personal care products. Choose latex-free gloves in latex-sensitized individuals. For atopic dermatitis: apply emollients twice daily to maintain skin hydration, avoid known irritants (soap, detergents, wool clothing), and keep fingernails short to reduce scratch damage. Bathe in lukewarm water with gentle fragrance-free soap. Proactive therapy (applying topical steroids to skin areas that frequently flare, twice weekly) prevents atopic dermatitis flares. Use hypoallergenic bedding and reduce house dust mite exposure. Seek medical review before introducing any new skin product if allergy-prone. Early introduction of diverse foods in infancy may reduce food allergy risk (per LEAP trial evidence).

Seek emergency care immediately if you experience throat swelling, difficulty breathing, dizziness, or a sudden drop in blood pressure — these are signs of anaphylaxis requiring epinephrine (adrenaline). Angioedema affecting the tongue or throat is a medical emergency. See a doctor promptly if hives are accompanied by systemic symptoms, if a skin rash rapidly worsens or spreads, if blistering or skin breakdown occurs, or if there is no improvement with over-the-counter antihistamines after 48-72 hours. Consult a dermatologist or allergist if your skin allergy is recurrent, significantly impairing quality of life or sleep, if patch testing is needed to identify a contact allergen, or if you are considering allergen immunotherapy.